D
Dingdang Health Technology Group
On-demand digital pharmacy and online medical consultation services
About Dingdang Health Technology Group
Dingdang Health Technology Group Ltd. is a digital health services provider in China, incorporated in 2014 and headquartered in Beijing. The company, founded by Yang Wenlong, who also serves as chairman of Renhe Pharmacy Company, has established an integrated online-to-offline business model. This model combines online medical consultations and pharmaceutical retail with a network of physical smart pharmacies for rapid delivery.
The company's core operations are divided into three main segments: a drug express business, online medical consultations, and chronic disease and health management. The drug express service operates through online direct sales, business distribution, and offline retail from its network of smart pharmacies, promising quick delivery of pharmaceutical and healthcare products. The online consultation platform provides users with 24/7 access to doctors and pharmacists for advice on medication and nutrition, leveraging AI-powered assistants. For chronic disease management, the company offers services like medication adherence, prescription renewals, and the creation of individualized health profiles, focusing on conditions such as oncology, liver disease, and diabetes.
Dingdang Health generates revenue primarily through the sale of pharmaceutical and healthcare products. Additional revenue streams include marketing services for third parties on its platforms and commission fees from merchants on its marketplace. The company has pursued a more asset-intensive strategy by building its own pharmacies to ensure service standards, a move that differentiates it from some asset-light competitors. The company was listed on the Hong Kong Stock Exchange in September 2022 after raising significant capital from investors including TPG Capital and OrbiMed Advisors. For the fiscal year 2023, the company reported total revenue of RMB 4.86 billion and has continued to focus on reducing costs and improving operational efficiency, narrowing its net loss significantly.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2021 | $220M | $880M | Yingke Capital | ↗ |
Growth signals
Latest recorded traffic for Dingdang Health Technology Group is 290 monthly website visits, down 42% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Dingdang Health Technology Group in its local ecosystem
The Dingdang Health Technology Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Yingke Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dingdang Health Technology Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dingdang Health Technology Group’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.